1. Home
  2. IMAB vs IHRT Comparison

IMAB vs IHRT Comparison

Compare IMAB & IHRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • IHRT
  • Stock Information
  • Founded
  • IMAB 2014
  • IHRT 1974
  • Country
  • IMAB United States
  • IHRT United States
  • Employees
  • IMAB N/A
  • IHRT N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • IHRT Broadcasting
  • Sector
  • IMAB Health Care
  • IHRT Consumer Discretionary
  • Exchange
  • IMAB Nasdaq
  • IHRT Nasdaq
  • Market Cap
  • IMAB 384.6M
  • IHRT 315.3M
  • IPO Year
  • IMAB 2020
  • IHRT 2019
  • Fundamental
  • Price
  • IMAB $3.69
  • IHRT $2.87
  • Analyst Decision
  • IMAB Strong Buy
  • IHRT Buy
  • Analyst Count
  • IMAB 5
  • IHRT 3
  • Target Price
  • IMAB $6.80
  • IHRT $2.92
  • AVG Volume (30 Days)
  • IMAB 1.7M
  • IHRT 810.0K
  • Earning Date
  • IMAB 11-02-2025
  • IHRT 11-06-2025
  • Dividend Yield
  • IMAB N/A
  • IHRT N/A
  • EPS Growth
  • IMAB N/A
  • IHRT N/A
  • EPS
  • IMAB N/A
  • IHRT N/A
  • Revenue
  • IMAB N/A
  • IHRT $3,867,156,000.00
  • Revenue This Year
  • IMAB N/A
  • IHRT $0.32
  • Revenue Next Year
  • IMAB N/A
  • IHRT $5.95
  • P/E Ratio
  • IMAB N/A
  • IHRT N/A
  • Revenue Growth
  • IMAB N/A
  • IHRT 3.18
  • 52 Week Low
  • IMAB $0.60
  • IHRT $0.95
  • 52 Week High
  • IMAB $5.90
  • IHRT $3.33
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 45.33
  • IHRT 69.25
  • Support Level
  • IMAB $3.20
  • IHRT $2.08
  • Resistance Level
  • IMAB $4.64
  • IHRT $3.33
  • Average True Range (ATR)
  • IMAB 0.41
  • IHRT 0.22
  • MACD
  • IMAB -0.17
  • IHRT 0.07
  • Stochastic Oscillator
  • IMAB 29.88
  • IHRT 64.20

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About IHRT iHeartMedia Inc.

iHeartMedia Inc is a United States-based audio media company. The company operates through the segments of the Multiplatform Group, the Digital Audio Group, and the Audio & Media Services Group. The company derives prime revenue from the Multiplatform Group segment which includes the company's Broadcast radio, Networks and Sponsorships, and Events businesses. The Digital Audio Group segment includes all of the company's digital businesses, including podcasting; and the Audio & Media Services Group includes Katz Media Group, a full-service media representation business, and RCS Sound Software, a provider of scheduling and broadcast software and services.

Share on Social Networks: